kalydeco

  1. Newly approved medicines for Cystic Fibrosis

    Here is an overview of each medicine to help guide you and your physician when making a treatment decision for Cystic Fibrosis: 

    完整阅读 »
  2. Kalydeco (ivacaftor) now approved in Canada for children aged 1-2

    Based on promising results from phase III clinical trials, Health Canada has decided to extend the use of Kalydeco (ivacaftor) to include children aged 1 to 2 years. 

    toddler in park with bubles

    完整阅读 »